Karnataka FDA revokes 16 pharmacy licences in fake drug probe
In short
Karnataka’s FDA revoked 16 pharmacy licences, suspended 8 more, and acted against a Pfizer distribution centre licence in a fake drug probe. Officials also seized fake medicines worth ₹5.05 crore from a farmhouse in Bidadi.
This matters because pharmacies and drug supply chains in the state could face more checks and restrictions. The reporting does not say what Pfizer’s statement said or whether more action will follow.
What the reporting says
Karnataka FDA revoked 16 pharmacy licences, suspended 8, and acted against a Pfizer C&F Distribution Centre licence amid a counterfeit drug probe. Officials also seized fake medicines worth ₹5.05 crore from a Bidadi farmhouse, according to the reporting. Pfizer issued a statement after the action, but the report does not state the contents of that statement or the full outcome of the probe.
Why it matters
Karnataka FDA action in a counterfeit drug probe led to the revocation of 16 pharmacy licences, suspension of 8 more, and action against the Pfizer C&F Distribution Centre licence. Officials also seized fake medicines worth ₹5.05 crore from a Bidadi farmhouse. The report says Pfizer issued a statement, but its contents are not stated, and the broader legal or business outcome remains unclear.